RECRUITING

Improve New Learning and Memory in Individuals With Mild Cognitive Impairment

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The current study is a double-blind, placebo-control randomized clinical trial examining the efficacy of memory retraining in individuals with Mild Cognitive Impairment (MCI). Impairment in higher level cognitive processing, such as new learning and memory, is one of the most common deficits in individuals with MCI and such deficits have been shown to exert significant negative impact on multiple aspects of everyday life, including occupational and social functioning. Despite these findings, few studies have attempted to treat these cognitive deficits in order to improve the everyday functioning of individuals with MCI. Through a small randomized clinical trial, the investigators found that individuals with MCI with documented cognitive impairment show a significant improvement in their memory performance following a treatment protocol designed to facilitate learning. The current proposal will replicate this finding and further evaluate (a) the impact of the treatment on everyday functioning, (b) the long term efficacy of the treatment and (c) the utility of booster sessions in facilitating long-term treatment effects. We will randomly assign older individuals who meet criteria for a diagnosis of amnestic MCI to a memory retraining group or a placebo control group. Both groups will undergo baseline, immediate and long-term follow-up assessment consisting of: (1) a traditional neuropsychological battery, (2) an assessment of global functioning examining the impact of the treatment on daily activities, and (3) functional neuroimaging. This design will allow the investigators to evaluate the efficacy of this particular memory retraining technique in an aMCI population through the assessment of cognitive function via a standard evaluation. In addition, the investigators will be able to draw conclusions regarding the impact of this particular memory remediation program on everyday life from questionnaires completed by the participant and a significant other. Optional enrollment in pre- post neuroimaging will also allow the investigators to look at changes in the brain.

Official Title

Use of a Memory Technique to Improve New Learning and Memory in Individuals With Mild Cognitive Impairment

Quick Facts

Study Start:2023-06-28
Study Completion:2027-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05396248

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:60 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 60 or older.
  2. * read and speak English fluently.
  3. * Research based diagnosis of Amnestic Mild Cognitive Impairment
  1. * prior stroke or neurological injury/disease (i.e. traumatic brain injury, Multiple Sclerosis, or Stroke).
  2. * history of significant psychiatric illness (for example, bipolar disorder, schizophrenia, or psychosis).
  3. * significant alcohol or drug abuse history (inpatient treatment).
  4. * Benzodiazepines and steroid use

Contacts and Locations

Study Contact

Nancy Moore
CONTACT
1973-324-8450
nbmoore@kesslerfoundation.org
Nancy Chiaravalloti
CONTACT
973-324-8440
nchiaravalloti@kesslerfoundation.org

Principal Investigator

Nancy Chiaravalloti
PRINCIPAL_INVESTIGATOR
Kessler Foundation

Study Locations (Sites)

University of Michigan
Ann Arbor, Michigan, 48105
United States
Kessler Foundation Research Center
West Orange, New Jersey, 07052
United States

Collaborators and Investigators

Sponsor: Kessler Foundation

  • Nancy Chiaravalloti, PRINCIPAL_INVESTIGATOR, Kessler Foundation

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-28
Study Completion Date2027-03

Study Record Updates

Study Start Date2023-06-28
Study Completion Date2027-03

Terms related to this study

Keywords Provided by Researchers

  • Memory
  • learning
  • rehabilitation
  • aging
  • cognition

Additional Relevant MeSH Terms

  • Mild Cognitive Impairment